<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25054758</article-id>
      <article-id pub-id-type="pmc">4148285</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20143024</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pseudo-acne fulminans associated with oral isotretinoin<sup><xref ref-type="fn" rid="fn01">*</xref></sup>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grando</surname>
            <given-names>Luciana Rosa</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Leite</surname>
            <given-names>Oriete Gerin</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cestari</surname>
            <given-names>Tania Ferreira</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Universidade Federal do Rio Grande do Sul (UFRGS) - Porto Alegre
(RS), Brazil.</aff>
      <aff id="aff02"><label>2</label> Private practice - Campinas (SP), Brazil.</aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Luciana Rosa Grando, Av. Luiz Manoel Gonzaga, 23,
90470-280 - Porto Alegre - RS, Brazil. E-mail:
<email>lucianarosa920@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>4</issue>
      <fpage>657</fpage>
      <lpage>659</lpage>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>7</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>8</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Acne fulminans is a rare and serious condition characterized by the sudden onset
of nodular and ulcerative acne lesions associated with systemic symptoms. It has
been recognized a subset of patients with a sudden worsening of acne, often
during treatment with oral isotretinoin, but without the strong presence of
systemic involvement. Recognized by some authors as "pseudo-acne fulminans" or "
acne fulminans sine fulminans," we report a case with these features in order to
draw attention to the recognition and early management of this
manifestation.</p>
      </abstract>
      <kwd-group>
        <kwd>Acne vulgaris</kwd>
        <kwd>Acneiform eruptions</kwd>
        <kwd>Isotretinoin</kwd>
        <kwd>Prednisone</kwd>
        <kwd>Propionibacterium acnes</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p><italic>Acne fulminans</italic> (AF) was described for the first time in
1959.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> It is a rare
condition that affects mainly male young individuals and is characterized by the
abrupt onset of nodular acneic and ulcerative lesions, which may be accompanied by
fever, arthralgias, myalgias, and osteolytic lesions.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> The etiopathogenesis of AF is not completely
clarified and infectious, genetic, hormonal and immunological mechanisms have
already been proposed. There are cases related to the use of oral isotretinoin,
probably due to exaggerated hypersensitivity reactions of type III and IV, after
massive contact with <italic>Propionibacterium acnes </italic>antigens favored by
the fragility of the pilosebaceous epithelium induced by this drug.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup> Another theory is an altered neutrophil function, genetically
determined, with hyperreactivity to inflammatory mediators and decreased
phagocytosis of <italic>P. acnes </italic>which, in an augmented proportion, would
explain even the disease escapes at the start of therapy with oral
isotretinoin.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Male patient, 16-year-old, presented a clinical picture of papulous-pustular acne,
with some nodular and keloid scattered lesions on the trunk. Due to no response to
treatment with adapalene 0.1% and tetracycline 1000mg/day, 0.6mg/kg/day of oral
isotretinoin was prescribed. By the end of the first month, improvement of facial
lesions was observed, however nodular and ulcerated lesions appeared on the trunk
(<xref ref-type="fig" rid="f01">Figures 1A</xref>, <xref ref-type="fig" rid="f01">1B</xref> and <xref ref-type="fig" rid="f01">1C</xref>). There was no
report of fever, arthralgias or other systemic symptoms and the laboratory exams
remained within normal parameters. Since there was no improvement until the third
month of treatment, it was opted to associate prednisone 0.6mg/kg/day and oral
isotretinoin reduced to 0.3mg/Kg/day, obtaining the control of lesions in the course
of 3 months with this therapeutical regimen. By the end of a 6-month period the
total 7200mg (120mg/kg) dose of isotretinoin was reached and corticotherapy was
gradually reduced over a 2-month period. There was global improvement of the acneic
clinical picture, with persistence of cicatricial lesions. The patient had a body
weight increase of 15 kg, which cannot be totally attributed to the use of oral
prednisone (<xref ref-type="fig" rid="f02">Figures 2A</xref>, <xref ref-type="fig" rid="f02">2B</xref> and <xref ref-type="fig" rid="f02">2C</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>The end of the first month of treatment with oral isotretinoin.
<bold>A</bold>. Onset of nodular and ulcerated lesions on the back;
<bold>B</bold>. Zoomedin view of the back; <bold>C</bold>. Nodular and
ulcerative lesions on the front of thorax</p>
        </caption>
        <graphic xlink:href="abd-89-04-0657-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p><bold>A</bold>. View of the back, by the end of treatment with isotretinoin
at the accumulated dose of 7200mg (120mg/Kg) and 5 months of corticotherapy
with prednisone (0.6mg/kg for 3 months, and gradual reduction for 2 months);
<bold>B</bold>. Zoomed-in view of the back, by the end of treatment with
isotretinoin associated to oral prednisone; <bold>C</bold>. View of front of
thorax, by the end of treatment with isotretinoin and oral prednisone</p>
        </caption>
        <graphic xlink:href="abd-89-04-0657-g02"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The occurrence of AF is a rare event, although described in several articles in the
worldwide literature. Without clear etiopathogenesis, it is characterized by a
clinical picture of severe acute febrile ulcerative acne and may be related to
several triggering factors. Five criteria for the diagnosis of AF were proposed by
Burns and Colville: <bold>1) </bold>sudden onset of lesions; <bold>2) </bold>severe
ulcerated acne which determine cicatricial lesions; <bold>3) </bold>systemic
symptoms like fever and polyarthralgia; <bold>4) </bold>absence of response to
antibiotics; <bold>5) </bold>favorable response to corticosteroid therapy.<sup><xref rid="r01" ref-type="bibr">1</xref></sup></p>
      <p>The manifestations of sudden worsening of acne without systemic symptoms
characterizes a subgroup called "pseudo-acne fulminans" or "<italic>acne fulminans
sine fulminans</italic>", described in few scientific reports. These patients
present cutaneous lesions with severity comparable to AF, however without the
clinical-laboratory systemic findings.</p>
      <p>The most accepted ethiology for the onset of pseudo-acne fulminans would be a
hypersensitivity reaction to bacterial agents of <italic>P. acnes </italic>released
during treatment with oral isotretinoin. It is speculated that changes in innate
immunity determine deviations in the production of interleukins and exacerbated
neutrophilic function, generating necrotizing ulcerative skin lesions.<sup><xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>Thomson e Cunliffe<sup><xref rid="r07" ref-type="bibr">7</xref></sup> reported 14
cases of acne with severity comparable to AF but without systemic involvement. The
majority of patients were male (78%), with mean age of 17 and had moderate acne
history. A common characteristic to virtually all patients was the presence of
macro-comedones and use of oral isotretinoin before the onset of the clinical
picture. Patients were treated with a combination of low isotretinoin and
prednisolone dose with excellent response.</p>
      <p>It is probable that the patients with severe disease of sudden onset present a
similar ethiology with and without the presence of systemic symptoms. The behavior
of the disease and, therefore, the handling of it also seem to be similar.<sup><xref rid="r07" ref-type="bibr">7</xref></sup> The use of corticotherapy to
control <italic>acne fulminans </italic>is acknowledged, associated or not with low
doses of oral isotretinoin.<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r09" ref-type="bibr">9</xref></sup> The best results were obtained with
the association of corticotherapy and oral isotretinoin.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> Paradoxically, the same drug which may trigger AF
or "<italic>pseudo-fulminans</italic>" is part of patient management, and should be
maintained in reduced doses until the stabilization of the symptoms, as well as
possibly increased later according to the clinical response of the
patient.<sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>Since the routine implementation of a protocol that combines the use of oral
isotretinoin and corticoids simultaneously from the start of severe inflammatory
acne treatment, Kaminsky et. al did not observe this effect anymore, concluding that
"<italic>pseudo-acne fulminans</italic>" is a preventable complication in oral
isotretinoin treatment<sup><xref rid="r10" ref-type="bibr">10</xref></sup> . In
cases where manifestations occur during treatment with the retinoid, the authors
propose early introduction of prednisone at a dose of 0.5 a 1.0 mg/kg/day for 4 to 6
weeks, gradually and slowly decreasing later on. Oral isotretinoin can be maintained
at a dose of 0.5 mg/kg/day, increasing it according to reduction of
corticosteroid.<sup><xref rid="r10" ref-type="bibr">10</xref></sup></p>
      <p>The introduction of systemic antibiotics is necessary when secondary infections are
present and must be prescribed according to the antibiogram.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> It is imperative to emphasize the
contraindication of prescribing tetracyclines and their derivatives in association
with isotretinoin, due to the risk of developing intracranial hypertension.</p>
      <p>It is important to recognize this sub-group of patients, who have severe acne of
sudden onset without systemic symptoms, since its management must be promptly
modified in order to avoid deforming scars. With the evidences currently available,
it is also proposed, as a way to prevent pseudo-acne fulminans, to start previous
treatment of macro-comedones and begin therapy with isotretinoin at low doses,
associated or not with oral corticoids until total remission of symptoms.<sup><xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r10" ref-type="bibr">10</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interests: None.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work performed at a private clinic - Porto Alegre (RS), Brazil.</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Grando LR, Leite OG, Cestari TF. Pseudo-acne fulminans
associated with oral isotretinoin. An Bras Dermatol. 2014;89(4):657-9.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burns</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Colville</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Acne conglobata with septicemia</article-title>
          <source>Arch Dermatol</source>
          <year>1959</year>
          <volume>79</volume>
          <fpage>361</fpage>
          <lpage>363</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karvonen</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Acne fulminans: report of clinical findings and treatment of
twentyfour patients</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1993</year>
          <volume>28</volume>
          <fpage>572</fpage>
          <lpage>579</lpage>
          <pub-id pub-id-type="pmid">7681856</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mehrany</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kist</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Weenig</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Witman</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Acne fulminans</article-title>
          <source>Int J Dermatol</source>
          <year>2005</year>
          <volume>44</volume>
          <fpage>132</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">15689212</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaba</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jarmuda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Czarnecka-Operacz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Silny</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Acne fulminans: explosive systemic form of acne</article-title>
          <source>J Eur Acad Dermatol Venereol</source>
          <year>2011</year>
          <volume>25</volume>
          <fpage>501</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">21029206</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perkins</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Crocket</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Hodgins</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Mackie</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Lackie</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>The effect of treatment with 13-cis-retinoic acid on the
metabolic burst of peripheral blood neutrophils from patients with
acne</article-title>
          <source>Br J Dermatol</source>
          <year>1991</year>
          <volume>124</volume>
          <fpage>429</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="pmid">1828174</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moreno</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Feliu</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Camacho</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Pseudo-acne fulminans caused by isotretinoin</article-title>
          <source>Med Cutan Ibero Lat Am</source>
          <year>1988</year>
          <volume>16</volume>
          <fpage>59</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">2967410</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomson</surname>
              <given-names>KF</given-names>
            </name>
            <name>
              <surname>Cunliffe</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Acne fulminans "sine fulminans"</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>299</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="pmid">10971490</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seukeran</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Cunliffe</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>The treatment of acne fulminans: a review of 25
cases</article-title>
          <source>Br J Dermatol</source>
          <year>1999</year>
          <volume>141</volume>
          <fpage>307</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="pmid">10468806</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mehra</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Borelli</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Burgdorf</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>R&#xF6;cken</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schaller</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Treatment of severe acne with low-dose
isotretinoin</article-title>
          <source>Acta Derm Venereol</source>
          <year>2012</year>
          <volume>92</volume>
          <fpage>247</fpage>
          <lpage>248</lpage>
          <pub-id pub-id-type="pmid">22377969</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaminsky</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Less common methods to treat acne</article-title>
          <source>Dermatology</source>
          <year>2003</year>
          <volume>206</volume>
          <fpage>68</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">12566807</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
